MAP1B related syndrome: Case presentation and review of literature.
Axons
/ metabolism
Brain
/ growth & development
Codon, Nonsense
/ genetics
Developmental Disabilities
Exome
/ genetics
Female
Fragile X Mental Retardation Protein
/ genetics
Gene Expression Regulation, Developmental
/ genetics
Genetic Predisposition to Disease
Humans
Infant
Infant, Newborn
Intellectual Disability
/ genetics
Microtubule-Associated Proteins
/ genetics
Pregnancy
Prenatal Exposure Delayed Effects
/ genetics
Exome Sequencing
/ methods
MAP1B
PVNH
WES
dysmorphic
intellectual disability
Journal
American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
23
02
2019
revised:
14
06
2019
accepted:
16
06
2019
pubmed:
19
7
2019
medline:
4
8
2020
entrez:
19
7
2019
Statut:
ppublish
Résumé
The microtubule-associated protein 1B (MAP1B) gene serves an important role in axonal growth and brain development. Its expression is known to be elevated in regions that retain high brain plasticity and is regulated by the fragile X mental retardation protein. MAP1B mutations have recently been associated with a phenotype including periventricular nodular heterotopia (PVNH), intellectual disability (ID), seizures, and dysmorphic features. We describe a child presenting with global developmental delays, ID, microcephaly, short stature, seizures, dysmorphic features, and prenatal alcohol exposure with a de novo nonsense MAP1B mutation (c.2035G>T, p.Glu679X) detected on whole exome sequencing (WES). His brain MRI showed PVNH and dysgenesis of the corpus callosum. While significant prenatal alcohol exposure could have modified his phenotype, we believe that this patient presents with features that cannot be explained by fetal alcohol exposure alone. This is the first case report that describes dysmorphic features associated with MAP1B mutations in detail along with supporting pictures and review of previous reported phenotypes. This case not only highlights the value of WES as a screening tool for unrecognized syndromes, but also supports the need for a better description of the phenotype associated with newly detected genetic syndromes by molecular screening.
Identifiants
pubmed: 31317654
doi: 10.1002/ajmg.a.61280
doi:
Substances chimiques
Codon, Nonsense
0
FMR1 protein, human
0
MAP1B protein, human
0
Microtubule-Associated Proteins
0
Fragile X Mental Retardation Protein
139135-51-6
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1703-1708Informations de copyright
© 2019 Wiley Periodicals, Inc.